Logo image of EXAS

EXACT SCIENCES CORP (EXAS) Stock Analyst Ratings

NASDAQ:EXAS - Nasdaq - US30063P1057 - Common Stock - Currency: USD

56.89  -0.92 (-1.59%)

After market: 56.89 0 (0%)

Buy % Consensus

85

ChartMill assigns a Buy % Consensus number of 85% to EXAS. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 70.68. This target is 24.24% above the current price.
EXAS was analyzed by 34 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about EXAS.
In the previous month the buy percentage consensus was at a similar level.
EXAS was analyzed by 34 analysts, which is quite many. So the average rating should be quite meaningful.
EXAS Historical Analyst RatingsEXAS Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -101 -92 -83 -74 -65 -56 -47 -38 -29 -20 -11 -2 10 20 30

Price Target & Forecast

Price Low Median Mean High 56.8954.5469.7170.6894.50 - -4.13% 22.53% 24.24% 66.11%
EXAS Current Analyst RatingEXAS Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 5 10 15
Up and Down Grades
Date Firm Action Rating
2025-05-02 RBC Capital Maintains Sector Perform -> Sector Perform
2025-05-02 Barclays Maintains Overweight -> Overweight
2025-05-02 Evercore ISI Group Maintains Outperform -> Outperform
2025-05-02 Baird Maintains Outperform -> Outperform
2025-04-11 Guggenheim Reiterate Buy -> Buy
2025-04-10 Mizuho Initiate Outperform
2025-04-10 Barclays Maintains Overweight -> Overweight
2025-03-13 RBC Capital Initiate Sector Perform
2025-02-26 Piper Sandler Maintains Overweight -> Overweight
2025-02-24 ScotiaBank Maintains Sector Outperform -> Sector Outperform
2025-02-20 Barclays Maintains Overweight -> Overweight
2025-02-20 B of A Securities Maintains Buy -> Buy
2025-01-23 Barclays Initiate Overweight
2025-01-13 Benchmark Reiterate Buy -> Buy
2024-12-13 B of A Securities Maintains Buy -> Buy
2024-11-26 TD Cowen Maintains Buy -> Buy
2024-11-26 BTIG Maintains Buy -> Buy
2024-11-11 Piper Sandler Maintains Overweight -> Overweight
2024-11-06 TD Cowen Maintains Buy -> Buy
2024-11-06 BTIG Maintains Buy -> Buy
2024-11-06 Benchmark Maintains Buy -> Buy
2024-11-06 Stifel Maintains Buy -> Buy
2024-11-06 Evercore ISI Group Maintains Outperform -> Outperform
2024-11-06 Baird Maintains Outperform -> Outperform
2024-11-06 Canaccord Genuity Maintains Buy -> Buy
2024-11-06 Goldman Sachs Maintains Buy -> Buy
2024-11-06 Craig-Hallum Maintains Buy -> Buy
2024-11-06 Citigroup Maintains Buy -> Buy
2024-11-06 Jefferies Maintains Buy -> Buy
2024-10-30 Bernstein Maintains Outperform -> Outperform